Kerntke Otto McGlone Wealth Management Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-1,646
Closed -$204K – 80
2024
Q2
$204K Sell
1,646
-14
-0.8% -$1.8K 0.19% 72
2024
Q1
$219K Buy
+1,660
New +$205K 0.22% 66
2021
Q3
– Sell
-9,982
Closed -$776K – 97
2021
Q2
$776K Sell
9,982
-632
-6% -$47K 0.31% 54
2021
Q1
$781K Buy
10,614
+1,180
+13% +$87K 0.41% 50
2020
Q4
$736K Buy
9,434
+117
+1% +$8.95K 0.43% 52
2020
Q3
$737K Buy
9,317
+1,422
+18% +$111K 0.54% 49
2020
Q2
$582K Buy
7,895
+365
+5% +$27.5K 0.53% 47
2020
Q1
$553K Buy
7,530
+319
+4% +$25.1K 0.62% 44
2019
Q4
$626K Buy
+7,211
New +$592K 0.53% 52

Other funds holding MRK

Kerntke Otto McGlone Wealth Management Group's MRK Position: Q3 2024 in Review

Kerntke Otto McGlone Wealth Management Group sold out of Merck (MRK) in Q3 2024, closing a stake of 1,646 shares — an estimated $204K sold.

Kerntke Otto McGlone Wealth Management Group first reported a position in MRK in Q4 2019 and held it in 9 quarters. The position peaked at $781K in Q1 2021. 3,497 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Kerntke Otto McGlone Wealth Management Group reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Kerntke Otto McGlone Wealth Management Group sold 1,646 Merck shares in Q3 2024, an estimated $204K.
  • Kerntke Otto McGlone Wealth Management Group first reported a position in Merck in Q4 2019 and held it in 9 quarters.
  • Kerntke Otto McGlone Wealth Management Group's Merck position peaked at $781K in Q1 2021.
  • 3,497 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Kerntke Otto McGlone Wealth Management Group's 13F filing for Q3 2024, filed 12 Nov 2024.